HomeInfliximab AxxqInfliximab Axxq + Infliximab

Does Infliximab Axxq Interact with Infliximab?

Infliximab Axxq and Infliximab have a unknown drug interaction according to U.S. FDA drug labeling data. Concomitant MTX use may decrease the incidence of anti-drug antibody production and increase infliximab product concentrations. Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of CD including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates. Therefore, it is expected that for a molecule that antagonizes cytokine activity, such as infliximab products, the formation of CYP450 enzymes could be normalized. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Infliximab Axxq Class
Tumor Necrosis Factor Blocker
Infliximab Class
Tumor Necrosis Factor Blocker
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Infliximab Axxq and your doctor is considering prescribing Infliximab (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Infliximab Axxq(Avsola)+💊 Infliximab(Infliximab)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Tumor Necrosis Factor Blocker
Drug B class
Tumor Necrosis Factor Blocker
Source
FDA drug label - infliximab-axxq

What this means in plain English

Concomitant MTX use may decrease the incidence of anti-drug antibody production and increase infliximab product concentrations. Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of CD including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates. Therefore, it is expected that for a molecule that antagonizes cytokine activity, such as infliximab products, the formation of CYP450 enzymes could be normalized.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Infliximab Axxq and Infliximab against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.